Related Experiment Video
Updated: Jul 7, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
miRNAs: Little known mediators of oncogenesis
Andrei L Gartel1, Eugene S Kandel
1Department of Medicine, University of Illinois at Chicago, 840, South Wood Street, Room 1041, Chicago, IL 60612, United States. agartel@uic.edu
Abstract:
Cancer progression is mediated by overexpression of oncogenes and downregulation or loss of tumor suppressors. Proteins, which were traditionally categorized into these groups, have been recently joined by a species of RNA molecules known as microRNAs (miRNAs). miRNAs belong to a class of approximately 22-nt-long non-coding RNAs found in eukaryotes that hinder gene expression by inducing degradation or inhibiting translation of select mRNAs. A growing number of miRNAs have been implicated in promoting or suppressing tumorigenesis in a variety of tissues. The supporting evidence ranges from suggestive expression profiling data to direct functional validation using methods of forward and reverse genetics. We discuss the nature of published results, as well as the merits and pitfalls of various approaches aimed at identification of cancer-related miRNAs and their mRNA targets.
Insights
MicroRNAs (miRNAs) are non-coding RNAs that regulate gene expression and are increasingly recognized for their roles in cancer. This study reviews methods for identifying cancer-related miRNAs and their mRNA targets.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Cancer progression involves oncogenes and tumor suppressors.
- MicroRNAs (miRNAs), small non-coding RNAs, are emerging regulators of gene expression.
- miRNAs are implicated in both promoting and suppressing tumorigenesis across various tissues.
Purpose of the Study:
- To review the role of miRNAs in cancer progression.
- To discuss methodologies for identifying cancer-related miRNAs.
- To evaluate approaches for determining miRNA-mRNA targets.
Main Methods:
- Literature review of published results.
- Analysis of expression profiling data.
- Functional validation using forward and reverse genetics.
Main Results:
- A growing body of evidence links specific miRNAs to cancer development.
- Various genetic and expression profiling techniques are used to identify these miRNAs.
- Challenges exist in validating miRNA-cancer associations and target interactions.
Conclusions:
- MicroRNAs are critical players in cancer biology.
- Robust methodologies are essential for accurate identification and validation of cancer-related miRNAs.
- Understanding miRNA functions is key to developing novel cancer therapies.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

